ST
Simon Turner
Partner
Sofinnova Partners
AI is changing both the pace and the possibilities of modern biology. From protein folding to drug discovery, machine learning is unlocking insights once out of reach. This panel brings together pioneers at the intersection of computation, life sciences, and the investors backing them to explore how algorithms are transforming research, redefining biotech company-building, and reshaping how we think about disease. Join us for breakfast as we unpack what it really means to go from code to cure — and what’s coming next.